Abingdon Health (LON:ABDX) Releases Earnings Results

Abingdon Health (LON:ABDX) released its earnings results on Tuesday. The company reported GBX (0.51) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Stock Down 7.1%

Shares of ABDX traded down GBX 0.68 during midday trading on Wednesday, reaching GBX 8.82. 338,629 shares of the stock were exchanged, compared to its average volume of 236,557. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. Abingdon Health has a 52 week low of GBX 5.50 and a 52 week high of GBX 13. The company’s 50 day moving average is GBX 10.74 and its two-hundred day moving average is GBX 10.52. The company has a market capitalization of £22.30 million, a P/E ratio of -10.89 and a beta of 0.13.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.